Home > Professionals > Cellulaire therapie > Patients with a planned alloHCT > MPOH08 – MaaT033 Phoebus

MPOH08 – MaaT033 Phoebus

A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematopoietic cell transplantation complications https://clinicaltrials.gov/study/NCT05762211?term=phoebus&rank=1

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 13-1-2026, 23:06